glp-1 obesity drug news Chart: 1 in 8 Americans Now Use Drugs for Weight Loss glp-1 obesity drug news today
Description
doi:10.1016/j.cmet.2018.03.001 87
Future challenges: Advancements have been made, but some key issues still remain
Lillys oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial | Eli Lilly and Company [Internet]
CNS/GI Medications : Opioids and anticholinergics can worsen GI side effects, while timing adjustments may be needed for some antidepressants or corticosteroids
